“Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association” was published today. The statement provides a thorough examination of statin safety and tolerability based on the highest quality evidence available. Associate Professor David Preiss was a lead member of the Writing Group for the committee.
Statin safety
10 December 2018
Latest news
“Switching off” the ovaries reduces the risk of breast cancer recurrence by one-fifth in younger women
1 May 2026
Study shows suppressing ovarian function can significantly lower breast cancer recurrence risk in younger women already taking tamoxifen.
RECOVERY trial hailed as one of the two success stories of the COVID-19 pandemic
16 April 2026
The Chair of the COVID-19 Inquiry has described the RECOVERY trial’s identification of the drug dexamethasone as ‘one of the two success stories of the pandemic’.